Cargando…
Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989502/ https://www.ncbi.nlm.nih.gov/pubmed/36894285 http://dx.doi.org/10.1016/j.jaip.2022.11.049 |
| _version_ | 1784901778058248192 |
|---|---|
| author | Marcus-Mandelblit, Nufar Ashkenazi-Hoffnung, Liat Scheuerman, Oded |
| author_facet | Marcus-Mandelblit, Nufar Ashkenazi-Hoffnung, Liat Scheuerman, Oded |
| author_sort | Marcus-Mandelblit, Nufar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9989502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99895022023-03-07 Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” Marcus-Mandelblit, Nufar Ashkenazi-Hoffnung, Liat Scheuerman, Oded J Allergy Clin Immunol Pract Correspondence and Replies Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology 2023-03 2023-03-07 /pmc/articles/PMC9989502/ /pubmed/36894285 http://dx.doi.org/10.1016/j.jaip.2022.11.049 Text en © 2023 Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence and Replies Marcus-Mandelblit, Nufar Ashkenazi-Hoffnung, Liat Scheuerman, Oded Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title | Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title_full | Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title_fullStr | Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title_full_unstemmed | Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title_short | Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients” |
| title_sort | reply to “sars-cov-2 reinfection or persistence among immunodeficient patients” |
| topic | Correspondence and Replies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989502/ https://www.ncbi.nlm.nih.gov/pubmed/36894285 http://dx.doi.org/10.1016/j.jaip.2022.11.049 |
| work_keys_str_mv | AT marcusmandelblitnufar replytosarscov2reinfectionorpersistenceamongimmunodeficientpatients AT ashkenazihoffnungliat replytosarscov2reinfectionorpersistenceamongimmunodeficientpatients AT scheuermanoded replytosarscov2reinfectionorpersistenceamongimmunodeficientpatients |